Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Pharmaceutical composition for postpartum liver depression qi stagnation type hypogalactia and preparing method thereof

A technology of liver stagnation and qi stagnation type and composition, applied in the field of pharmacy, can solve the problems of lack of effective clinical treatment drugs and the like, and achieve the effects of no toxic side effects, high safety and definite curative effect

Inactive Publication Date: 2014-07-16
许文
View PDF3 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0008] However, there is still a lack of effective clinical treatment drugs for Western medicine to treat postpartum hypogalactia. Traditional Chinese medicine has accumulated rich clinical experience and treatment theories in the prevention and treatment of postpartum hypogalactia.
There are already many kinds of Chinese patent medicines for preventing and treating postpartum milk deficiency in the clinical market. However, according to the different clinical symptoms and signs of patients, and different individual constitutions, the existing Chinese patent medicines are not enough to meet the needs of the clinical market, which requires the production of A new drug that can target specific clinical manifestations, specific clinical syndrome types, and perform targeted therapy with significant clinical efficacy

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0069] When the dosage form of the pharmaceutical composition is a tablet, the preparation method comprises the following steps:

[0070] The first step is to mix the various raw materials of the traditional Chinese medicine in proportion, add ethanol with an alcohol concentration of 85% to 90% relative to the mass of the mixture, heat and reflux for 2 to 4 hours, extract, and filter to obtain the first extraction. liquid; the medicinal dregs obtained by filtering are then added with ethanol with an alcohol concentration of 90% to 95% relative to the quality of the medicinal dregs 2 to 3 times, heated and refluxed for 1 to 3 hours, extracted, and filtered to obtain a second extract; The first extract and the second extract are combined, concentrated under reduced pressure to remove the ethanol solvent, and dried to obtain a dry paste;

[0071] In the second step, the dry paste obtained in the first step is placed in an ultrafine pulverizer for 2 to 3 hours, pulverized, and sie...

Embodiment 1

[0084] Example 1 tablet

[0085] The embodiment of the present invention provides a pharmaceutical composition for treating postpartum liver depression and qi stagnation type hypogalactia, the parts by weight of the raw materials are: 15 parts by weight of green skin, 16 parts by weight of litchi core, and 21 parts by weight of Cyperus cyperi , 15 parts by weight of bergamot, 15 parts by weight of citron, 15 parts by weight of rose, 13 parts by weight of green calyx plum, 17 parts by weight of scorpion, 14 parts by weight of vine, 12 parts by weight of summer, 20 parts by weight of motherwort, 19 parts by weight of orchid, 15 parts by weight of Caulis Spatholobus, 8 parts by weight of Wang Buliuxing, 15 parts by weight of Valerian Root, 12 parts by weight of Albizia Julibrissin, 16 parts by weight of Codonopsis radix, 20 parts by weight of Astragalus, 20 parts by weight of Chinese yam, Rhodiola rosea 7 parts by weight, 15 parts by weight of sea buckthorn, 15 parts by weight of...

Embodiment 2

[0090] Example 2 Injection

[0091] The embodiment of the present invention provides a pharmaceutical composition for treating postpartum liver depression and qi stagnation type hypogalactia, the parts by weight of the raw materials are: 15 parts by weight of green skin, 16 parts by weight of litchi core, and 21 parts by weight of Cyperus cyperi , 15 parts by weight of bergamot, 15 parts by weight of citron, 15 parts by weight of rose, 13 parts by weight of green calyx plum, 17 parts by weight of scorpion, 14 parts by weight of vine, 12 parts by weight of summer, 20 parts by weight of motherwort, 19 parts by weight of orchid, 15 parts by weight of Caulis Spatholobus, 8 parts by weight of Wang Buliuxing, 15 parts by weight of Valerian Root, 12 parts by weight of Albizia Julibrissin, 16 parts by weight of Codonopsis radix, 20 parts by weight of Astragalus, 20 parts by weight of Chinese yam, Rhodiola rosea 7 parts by weight, 15 parts by weight of seabuckthorn, 15 parts by weight ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Particle sizeaaaaaaaaaa
Login to View More

Abstract

The invention discloses a pharmaceutical composition for liver qi stagnation type hypogalactia and a preparing method thereof. The pharmaceutical composition comprises the following raw medical materials of pericarpium citri reticulatae viride, semen litchi, rhizoma cyperi, finger citron, citron fruits, roses, Armeniaca mume, semen aesculi, herba aristolochiae, corydalis decumbens, herba leonuri, herba lycopi, caulis spatholobi, cowherb seeds, valeriana officinalis, cortex albiziae, radix codonopsis, astragalus, yam, rhodiola, sea buckthorn, micromeria biflora benth, lilies, radix ophiopogonis and goodyera kwangtungensis tso. The pharmaceutical composition has the advantages that the traditional theories of traditional Chinese medicine are utilized, the pharmaceutical composition is mainly used for soothing liver-qi stagnation and activating collaterals and promoting lactation, the major function of the pharmaceutical composition is treating the liver qi stagnation type hypogalactia, and the pharmaceutical composition is quick in effect, accurate in curative effect, high in security, non-poisonous and non-side-effect, and the live qi stagnation type hypogalactia can not easily occur.

Description

[0001] technical field [0002] The invention relates to the technical field of pharmacy, in particular to a pharmaceutical composition and a preparation method for hypogalactia due to postpartum liver depression and qi stagnation. [0003] Background technique [0004] The puerpera has little or no milk when breastfeeding, and those who are not enough or even unable to feed the baby are called postpartum hypogalactia. The degree and situation of lack of milk are different: some lack milk at the beginning of breastfeeding, and then a little more but still not enough; some have no milk at all and cannot breastfeed at all; Sudden lack of milk, not enough to feed the baby. [0005] Clinical symptoms: Most of them occur within 2-3 days to half a month after delivery. In addition to being closely related to mammary gland development, milk secretion is largely dependent on sucking stimulation during breastfeeding. In addition, it is closely related to maternal nutrition, sleep...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/898A61K36/9062A61P15/14A61K9/20A61K9/00A61K9/08
CPCA61K9/0014A61K9/0019A61K9/2059A61K36/185A61K36/264A61K36/344A61K36/36A61K36/41A61K36/48A61K36/481A61K36/486A61K36/53A61K36/533A61K36/66A61K36/736A61K36/738A61K36/752A61K36/77A61K36/84A61K36/8905A61K36/8945A61K36/8967A61K36/8968A61K36/898A61K47/10A61K2236/333A61K2236/39A61K2236/51A61K2236/53A61K2300/00
Inventor 许文吕明云
Owner 许文
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products